A primer of drug action:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
New York
Freeman
1988
|
Ausgabe: | 5. ed. |
Schriftenreihe: | A series of books in psychology
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XIV, 364 S. Ill., graph. Darst. |
ISBN: | 0716719622 0716719630 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV007685437 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 930421s1988 ad|| |||| 00||| eng d | ||
020 | |a 0716719622 |9 0-7167-1962-2 | ||
020 | |a 0716719630 |9 0-7167-1963-0 | ||
035 | |a (OCoLC)17297525 | ||
035 | |a (DE-599)BVBBV007685437 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
050 | 0 | |a RM315 | |
080 | |a 615.015 | ||
082 | 0 | |a 615/.78 |2 19 | |
084 | |a XI 5800 |0 (DE-625)153018:12905 |2 rvk | ||
100 | 1 | |a Julien, Robert M. |e Verfasser |4 aut | |
245 | 1 | 0 | |a A primer of drug action |
250 | |a 5. ed. | ||
264 | 1 | |a New York |b Freeman |c 1988 | |
300 | |a XIV, 364 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a A series of books in psychology | |
650 | 2 | |a Psychoanaleptiques | |
650 | 7 | |a Psychofarmaca |2 gtt | |
650 | 4 | |a Psychopharmacologie | |
650 | 2 | |a Psychopharmacologie | |
650 | 4 | |a Psychotropes | |
650 | 4 | |a Psychopharmacology | |
650 | 4 | |a Psychotropic Drugs | |
650 | 4 | |a Psychotropic drugs | |
650 | 0 | 7 | |a Halluzinogen |0 (DE-588)4134941-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakokinetik |0 (DE-588)4115557-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Psychopharmakologie |0 (DE-588)4176249-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Empfängnisverhütungsmittel |0 (DE-588)4152090-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Wirkung |0 (DE-588)4190021-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
655 | 7 | |8 1\p |0 (DE-588)4151278-9 |a Einführung |2 gnd-content | |
689 | 0 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
689 | 0 | 1 | |a Pharmakokinetik |0 (DE-588)4115557-9 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
689 | 1 | 1 | |a Wirkung |0 (DE-588)4190021-2 |D s |
689 | 1 | |8 2\p |5 DE-604 | |
689 | 2 | 0 | |a Empfängnisverhütungsmittel |0 (DE-588)4152090-7 |D s |
689 | 2 | 1 | |a Pharmakokinetik |0 (DE-588)4115557-9 |D s |
689 | 2 | |8 3\p |5 DE-604 | |
689 | 3 | 0 | |a Psychopharmakologie |0 (DE-588)4176249-6 |D s |
689 | 3 | |8 4\p |5 DE-604 | |
689 | 4 | 0 | |a Halluzinogen |0 (DE-588)4134941-6 |D s |
689 | 4 | |8 5\p |5 DE-604 | |
856 | 4 | 2 | |m HEBIS Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005043086&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-005043086 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 5\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804122043600338944 |
---|---|
adam_text | A PRIMER OF DRUG ACTION
A comprehensive guide to the actions, uses,
and side effects of psychoactive drugs
ELEVENTH EDITION
ROBERT MJULIENMDPHD
42-
Claire 0 Advokat, Ph D
Louisiana State University
and Joseph E Comaty, Ph D M P
Louisiana State Dffice of Mental Health
WDRTH PUBLISHERS
Technische Umiveirsitat Darmstadt
Fachbereich 03
Institut fur Psychologie
Bibliothek
Alexanderstrasse 10; 64283 Darmstadt Inv Nr
Contents
Preface xi
Introduction to Psychopharmacology: How
Drugs Interact with the Body and the Brain 1
1 Pharmacokinetics: How Drugs Are Handled
by the Body 3
Drug Absorption / Drug Distribution / Termination of Drug
Action / Time Course of Drug Distribution and Elimination:
Concept of Drug Half-Life
2 Pharmacodynamics: How Drugs Act 38
Receptors for Drug Action / Dose-Response Relationships /
Drug Safety and Effectiveness
3 The Neuron, Synaptic Transmission, and
Neurotransmitters 63
Overall Organization of the Brain / The Neuron / Specific
Neurotransmitters
vi CONTENTS
Part 2
Drugs That Depress Brain Function: Sedative-
Hypnotic Drugs 93
4 Ethyl Alcohol and the Inhalants of Abuse 95
Ethyl Alcohol
Pharmacology of Alcohol / Tolerance and Dependence / Side
Effects and Toxicity / Teratogenic Effects / Alcoholism and Its
Pharmacological Treatment
Inhalants of Abuse
Why Inhalants Are Abused and Who Abuses Them / Medical
Consequences of Inhalant Abuse / Acute Intoxication and
Chronic Effects
Chapter 4 Appendix: What Is a Drink? How Much Alcohol Is in
My Drink?
5 Barbiturates, General Anesthetics, Gamma
Hydroxybutyrate (GHB), and Antiepileptic Drugs
Historical Background / Sites and Mechanisms of Action /
Sedative-Induced Brain Dysfunction
Specific Depressants
Barbiturates / Nonbarbiturate Sedative-Hypnotic Drugs
General Anesthetics
Gamma Hydroxybutyrate
Antiepileptic Drugs
Relationships Between Structure and Activity / Specific Agents /
Antiepileptic Drugs in Pregnancy
6 Benzodiazapines and Related Anxiolytic
Medications 169
Benzodiazepines / Flumazenil: A Benzodiazepine Receptor
Agonist / Benzodiazepine Receptor Agonist Hypnotics /
Ramelteon: A Selective Melatonin Receptor Agonist / Serotonin
Receptor Agonists as Anxiolytics / Anticonvulsants as
Anxiolytics
CONTENTS vii
Part 3*
Drugs That Are Used to Treat Psychological
Disorders 195
7 Antidepressant Drugs 197
Depression / First-Generation Antidepressants / Second-
Generation Antidepressants / Selective Serotonin Reuptake
Inhibitors / Dual-Action Antidepressants / Dopamine-
Norepinephrine Reuptake Inhibitor: Bupropion / Selective
Norepinephrine Reuptake Inhibitors / STAR*D Study /
Antidepressants of the Future
B Drugs Used to Treat Bipolar Disorder 252
Bipolar Disorder / STEP-BD Study / Lithium /
Neuromodulator Anticonvulsant Mood Stabilizers / Other
Uses for Anticonvulsant Mood Stabilizers / Atypical
Antipsychotics / Omega-3 Fatty Acids / Miscellaneous Agents /
Psychotherapeutic and Psychosocial Treatments
9 Antipsychotic Drugs 294
Schizophrenia / Historical Background and Classification of
Antipsychotic Drugs / CATIE and CUtLASS Studies / First-
Generation Antipsychotic Drugs: Phenothiazines / Alternative
First-Generation Antipsychotics / Second-Generation (Atypical)
Antipsychotic Drugs / Prominent Side Effects of Second-
Generation Antipsychotics / Additional Applications for
Second-Generation Antipsychotics
16 Child and Adolescent Psychopharmacology 341
Behavioral and Aggressive Disorders / Autism Spectrum
Disorders / Attention Deficit/Hyperactivity Disorder /
Depression in Children and Adolescents / Anxiety Disorders in
Children and Adolescents / Bipolar Disorder in Children and
Adolescents / Psychotic Disorders in Children and Adolescents
11 Geriatric Psychopharmacology 391
Inappropriate Drug Use in the Elderly / Control of Agitated and
Aggressive Behaviors in the Elderly / Undertreatment of the
Elderly: Focus on Depression / Parkinsons Disease /
Alzheimer s Disease
viii CONTENTS
12 Integrating Psychopharmacology and
Psychological Therapies in Patient Care 420
Limitations to Pharmacological Therapy / Developing a Plan to
Integrate Psychopharmacology and Psychological Therapies /
Clinical Examples / Limitations to Current Practice / Examples
of Areas of Needed Involvement
Chapter 12 Appendix: Quick Reference to Psychotropic Medication
_ Part_4 J
Drugs That Stimulate Brain Function:
Psychostimulants 439
13 Cocaine, the Amphetamines, and
Nonamphetamine Behavioral Stimulants 441
Cocaine
Forms of Cocaine / Pharmacokinetics / Mechanism of Action /
Pharmacological Effects in Human Beings / Comorbidity /
Cocaine and Pregnancy / Neurotoxicity of Cocaine /
Pharmacological Treatment of Cocaine Dependency / Novel
Approaches to the treatment of Cocaine Addiction
Amphetamines
Mechanism of Action / Pharmacological Effects / Dependence
and Tolerance / Methamphetamine
Nonamphetamine Behavioral Stimulants
14 Caffeine and Nicotine 479
Caffeine
Pharmacokinetics / Pharmacological Effects / Mechanism of
Action / Reproductive Effects / Tolerance and Dependence
Nicotine
Pharmacokinetics / Pharmacological Effects / Mechanism of
Action / Tolerance and Dependence / Toxicity / Effects of
Passive Smoke / Effects During Pregnancy / Therapy for
Nicotine Dependence
CONTENTS ix
Part 5 *
Analgesic Drugs and Psychedelics 513
15 Nonnarcotic Anti-Inflammatory Analgesics 515
Nonselective Cyclooxygenase Inhibitors / Selective COX-2
Inhibitors / Nonopioid Analgesics of the Future: Nitric Oxide-
Donating Analgesics
16 Opioid Analgesics 529
History / Terminology / Opioid Receptors / Classification of
Opioid Analgesics / Morphine: A Pure Opioid Agonist / Other
Pure Opioid Agonists / Partial Opioid Agonists / Mixed
Agonist-Antagonist Opioids / Pure Opioid Antagonists / Opioid
Combinations / Pharmacotherapy of Opioid Dependence
17 Cannabinoid Agonists and Antagonists 572
History / Mechanism of Action: Cannabinoid Receptor /
Pharmacokinetics / Pharmacological Effects / Tolerance and
Dependence / Therapeutic Uses of Cannabinoid Agonists /
Cannabinoid Antagonists
18 Psychedelic Drugs 606
Scopolamine: An Anticholinergic Psychedelic/
Catecholaminelike Psychedelics / Serotoninlike Psychedelics /
Glutaminergic NMDA Receptor Antagonists / Salvinorin A
Part 6 •
Special Topics in Psychopharmacology 638
19 Herbal Medicines for Psychological Disorders 639
St John s Wort / Ginkgo / Kava / Ephedrine (Ma-Huang) /
Other Herbals That Act on the CNS / Conclusions
20 Anabolic Steroids 661
Mechanism of Action / Effects / Side Effects / Physical
Dependence / Abuse and Treatment
CONTENTS
21 Topics in Drug Abuse 683
Historical and Current Perspectives / Extent of the Drug
Problem / Nosology and Psychopathology of Substance Abuse /
Drugs as Behavioral Reinforcers: Neurobiology of Drug
Dependence / Drug Availability / Addiction as a Chronic,
Relapsing Illness / Drug Education / Treatment Issues /
Pharmacotherapy of Substance Use Disorders
Glossary 709
Index 717
|
any_adam_object | 1 |
author | Julien, Robert M. |
author_facet | Julien, Robert M. |
author_role | aut |
author_sort | Julien, Robert M. |
author_variant | r m j rm rmj |
building | Verbundindex |
bvnumber | BV007685437 |
callnumber-first | R - Medicine |
callnumber-label | RM315 |
callnumber-raw | RM315 |
callnumber-search | RM315 |
callnumber-sort | RM 3315 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | XI 5800 |
ctrlnum | (OCoLC)17297525 (DE-599)BVBBV007685437 |
dewey-full | 615/.78 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.78 |
dewey-search | 615/.78 |
dewey-sort | 3615 278 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
edition | 5. ed. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02919nam a2200745 c 4500</leader><controlfield tag="001">BV007685437</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1988 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0716719622</subfield><subfield code="9">0-7167-1962-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0716719630</subfield><subfield code="9">0-7167-1963-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)17297525</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007685437</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM315</subfield></datafield><datafield tag="080" ind1=" " ind2=" "><subfield code="a">615.015</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.78</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5800</subfield><subfield code="0">(DE-625)153018:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Julien, Robert M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A primer of drug action</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">5. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Freeman</subfield><subfield code="c">1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 364 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">A series of books in psychology</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Psychoanaleptiques</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychofarmaca</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychopharmacologie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Psychopharmacologie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychopharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakologie</subfield><subfield code="0">(DE-588)4176249-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Empfängnisverhütungsmittel</subfield><subfield code="0">(DE-588)4152090-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkung</subfield><subfield code="0">(DE-588)4190021-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4151278-9</subfield><subfield code="a">Einführung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Wirkung</subfield><subfield code="0">(DE-588)4190021-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Empfängnisverhütungsmittel</subfield><subfield code="0">(DE-588)4152090-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Psychopharmakologie</subfield><subfield code="0">(DE-588)4176249-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="8">5\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HEBIS Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005043086&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005043086</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
genre | 1\p (DE-588)4151278-9 Einführung gnd-content |
genre_facet | Einführung |
id | DE-604.BV007685437 |
illustrated | Illustrated |
indexdate | 2024-07-09T17:07:36Z |
institution | BVB |
isbn | 0716719622 0716719630 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005043086 |
oclc_num | 17297525 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | XIV, 364 S. Ill., graph. Darst. |
publishDate | 1988 |
publishDateSearch | 1988 |
publishDateSort | 1988 |
publisher | Freeman |
record_format | marc |
series2 | A series of books in psychology |
spelling | Julien, Robert M. Verfasser aut A primer of drug action 5. ed. New York Freeman 1988 XIV, 364 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier A series of books in psychology Psychoanaleptiques Psychofarmaca gtt Psychopharmacologie Psychotropes Psychopharmacology Psychotropic Drugs Psychotropic drugs Halluzinogen (DE-588)4134941-6 gnd rswk-swf Pharmakokinetik (DE-588)4115557-9 gnd rswk-swf Psychopharmakologie (DE-588)4176249-6 gnd rswk-swf Empfängnisverhütungsmittel (DE-588)4152090-7 gnd rswk-swf Wirkung (DE-588)4190021-2 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 gnd rswk-swf 1\p (DE-588)4151278-9 Einführung gnd-content Psychopharmakon (DE-588)4047729-0 s Pharmakokinetik (DE-588)4115557-9 s DE-604 Wirkung (DE-588)4190021-2 s 2\p DE-604 Empfängnisverhütungsmittel (DE-588)4152090-7 s 3\p DE-604 Psychopharmakologie (DE-588)4176249-6 s 4\p DE-604 Halluzinogen (DE-588)4134941-6 s 5\p DE-604 HEBIS Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005043086&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 5\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Julien, Robert M. A primer of drug action Psychoanaleptiques Psychofarmaca gtt Psychopharmacologie Psychotropes Psychopharmacology Psychotropic Drugs Psychotropic drugs Halluzinogen (DE-588)4134941-6 gnd Pharmakokinetik (DE-588)4115557-9 gnd Psychopharmakologie (DE-588)4176249-6 gnd Empfängnisverhütungsmittel (DE-588)4152090-7 gnd Wirkung (DE-588)4190021-2 gnd Psychopharmakon (DE-588)4047729-0 gnd |
subject_GND | (DE-588)4134941-6 (DE-588)4115557-9 (DE-588)4176249-6 (DE-588)4152090-7 (DE-588)4190021-2 (DE-588)4047729-0 (DE-588)4151278-9 |
title | A primer of drug action |
title_auth | A primer of drug action |
title_exact_search | A primer of drug action |
title_full | A primer of drug action |
title_fullStr | A primer of drug action |
title_full_unstemmed | A primer of drug action |
title_short | A primer of drug action |
title_sort | a primer of drug action |
topic | Psychoanaleptiques Psychofarmaca gtt Psychopharmacologie Psychotropes Psychopharmacology Psychotropic Drugs Psychotropic drugs Halluzinogen (DE-588)4134941-6 gnd Pharmakokinetik (DE-588)4115557-9 gnd Psychopharmakologie (DE-588)4176249-6 gnd Empfängnisverhütungsmittel (DE-588)4152090-7 gnd Wirkung (DE-588)4190021-2 gnd Psychopharmakon (DE-588)4047729-0 gnd |
topic_facet | Psychoanaleptiques Psychofarmaca Psychopharmacologie Psychotropes Psychopharmacology Psychotropic Drugs Psychotropic drugs Halluzinogen Pharmakokinetik Psychopharmakologie Empfängnisverhütungsmittel Wirkung Psychopharmakon Einführung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005043086&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT julienrobertm aprimerofdrugaction |